Tharwat Haj

1.0k total citations
16 papers, 689 citations indexed

About

Tharwat Haj is a scholar working on Cellular and Molecular Neuroscience, Immunology and Rheumatology. According to data from OpenAlex, Tharwat Haj has authored 16 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cellular and Molecular Neuroscience, 8 papers in Immunology and 5 papers in Rheumatology. Recurrent topics in Tharwat Haj's work include Axon Guidance and Neuronal Signaling (8 papers), T-cell and B-cell Immunology (5 papers) and Biomarkers in Disease Mechanisms (3 papers). Tharwat Haj is often cited by papers focused on Axon Guidance and Neuronal Signaling (8 papers), T-cell and B-cell Immunology (5 papers) and Biomarkers in Disease Mechanisms (3 papers). Tharwat Haj collaborates with scholars based in Israel, Italy and United States. Tharwat Haj's co-authors include Elias Toubi, Aharon Kessel, Ayelet Snir, Regina Peri, Zahava Vadasz, Edmond Sabo, Doron Melamed, Gleb Slobodin, Itzhak Rosner and Michael Rozenbaum and has published in prestigious journals such as PLoS ONE, FEBS Letters and Annals of the Rheumatic Diseases.

In The Last Decade

Tharwat Haj

16 papers receiving 674 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tharwat Haj Israel 14 381 157 155 98 89 16 689
Will G. James Australia 10 440 1.2× 111 0.7× 52 0.3× 64 0.7× 44 0.5× 10 617
Volker Blaschke Germany 14 365 1.0× 131 0.8× 24 0.2× 91 0.9× 97 1.1× 26 677
Cosmin Tegla United States 18 414 1.1× 284 1.8× 25 0.2× 99 1.0× 113 1.3× 28 822
Kathrine Abell Denmark 14 227 0.6× 349 2.2× 91 0.6× 305 3.1× 30 0.3× 15 813
Takamasa Oono Japan 18 380 1.0× 256 1.6× 52 0.3× 355 3.6× 22 0.2× 63 1.1k
Xin Maggie Wang Australia 14 311 0.8× 170 1.1× 61 0.4× 197 2.0× 23 0.3× 20 685
Yunguang Liu China 11 102 0.3× 140 0.9× 72 0.5× 80 0.8× 40 0.4× 26 422
Ann E. Kelly-Welch United States 9 383 1.0× 185 1.2× 37 0.2× 104 1.1× 18 0.2× 10 672
Pamela Hall Australia 8 714 1.9× 92 0.6× 246 1.6× 69 0.7× 10 0.1× 11 852
AH Dalloul France 14 533 1.4× 238 1.5× 25 0.2× 145 1.5× 119 1.3× 24 917

Countries citing papers authored by Tharwat Haj

Since Specialization
Citations

This map shows the geographic impact of Tharwat Haj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tharwat Haj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tharwat Haj more than expected).

Fields of papers citing papers by Tharwat Haj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tharwat Haj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tharwat Haj. The network helps show where Tharwat Haj may publish in the future.

Co-authorship network of co-authors of Tharwat Haj

This figure shows the co-authorship network connecting the top 25 collaborators of Tharwat Haj. A scholar is included among the top collaborators of Tharwat Haj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tharwat Haj. Tharwat Haj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Haj, Tharwat, et al.. (2017). Semaphorin 3A: Is a key player in the pathogenesis of asthma. Clinical Immunology. 184. 70–72. 21 indexed citations
2.
Rimar, Doron, Itzhak Rosner, Gleb Slobodin, et al.. (2015). Semaphorin 3A: an immunoregulator in systemic sclerosis. Rheumatology International. 35(10). 1625–1630. 31 indexed citations
3.
Vadasz, Zahava, Tova Rainis, Afif Nakhleh, et al.. (2015). The Involvement of Immune Semaphorins in the Pathogenesis of Inflammatory Bowel Diseases (IBDs). PLoS ONE. 10(5). e0125860–e0125860. 19 indexed citations
4.
Vadasz, Zahava, Tharwat Haj, & Elias Toubi. (2014). The Role of B Regulatory Cells and Semaphorin3A in Atopic Diseases. International Archives of Allergy and Immunology. 163(4). 245–251. 17 indexed citations
5.
Rimar, Doron, Itzhak Rosner, Gleb Slobodin, et al.. (2014). AB0195 Semaphorin 3A as A Possible Immunoregulator in Systemic Sclerosis. Annals of the Rheumatic Diseases. 73. 868–868. 2 indexed citations
6.
Vadasz, Zahava, Tharwat Haj, Aharon Kessel, & Elias Toubi. (2013). B‐regulatory cells in autoimmunity and immune mediated inflammation. FEBS Letters. 587(13). 2074–2078. 56 indexed citations
7.
Vadasz, Zahava, Tharwat Haj, Regina Peri, et al.. (2013). A regulatory role for CD72 expression on B cells in systemic lupus erythematosus. Seminars in Arthritis and Rheumatism. 43(6). 767–771. 26 indexed citations
8.
Rimar, Doron, Itzhak Rosner, Gleb Slobodin, et al.. (2013). AB0141 Lysyl oxidase is correlated with fibrosis in systemic sclerosis. Annals of the Rheumatic Diseases. 72. A828–A828. 1 indexed citations
9.
Rimar, Doron, Itzhak Rosner, Gleb Slobodin, et al.. (2013). Brief Report: Lysyl Oxidase Is a Potential Biomarker of Fibrosis in Systemic Sclerosis. Arthritis & Rheumatology. 66(3). 726–730. 59 indexed citations
10.
Snir, Ayelet, et al.. (2012). B Cell‐Activating Factor Enhances Interleukin‐6 and Interleukin‐10 Production by ODN‐Activated Human B Cells. Scandinavian Journal of Immunology. 76(4). 371–377. 22 indexed citations
11.
Vadasz, Zahava, Tharwat Haj, Itzhak Rosner, et al.. (2012). Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus. Arthritis Research & Therapy. 14(3). R146–R146. 61 indexed citations
12.
Snir, Ayelet, Aharon Kessel, Tharwat Haj, et al.. (2011). Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy.. PubMed. 29(4). 697–700. 41 indexed citations
13.
Kessel, Aharon, Tharwat Haj, Regina Peri, et al.. (2011). Human CD19+CD25high B regulatory cells suppress proliferation of CD4+ T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells. Autoimmunity Reviews. 11(9). 670–677. 247 indexed citations
14.
Snir, Ayelet, Aharon Kessel, Tharwat Haj, et al.. (2011). Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy. Annals of the Rheumatic Diseases. 70. A57–A58. 34 indexed citations
15.
Kessel, Aharon, Regina Peri, Roberto Perricone, et al.. (2011). The autoreactivity of B cells in hereditary angioedema due to C1 inhibitor deficiency. Clinical & Experimental Immunology. 167(3). 422–428. 14 indexed citations
16.
Kessel, Aharon, Regina Peri, Tharwat Haj, et al.. (2010). IVIg Attenuates TLR-9 Activation in B Cells from SLE Patients. Journal of Clinical Immunology. 31(1). 30–38. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026